Cite
APA Citation
Koga, T., Kobayashi, Y., Tomizawa, K., Suda, K., Kosaka, T., Sesumi, Y., Fujino, T., Nishino, M., Ohara, S., Chiba, M., Shimoji, M., Takemoto, T., Suzuki, M., Jänne, P. A., & Mitsudomi, T. (2018). activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study. Lung cancer, 126, 72–79. http://access.bl.uk/ark:/81055/vdc_100074722715.0x000052